Notice2022-06368
Solicitation of Nominations for Organizational Representatives to the Advisory Committee on Heritable Disorders in Newborns and Children
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 28, 2022
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
HRSA is seeking nominations from organizations to send representatives to be a liaison to the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC or Committee). Selections will be based on a review of the organization's subject area of expertise, mission, relevancy, and benefit provided relative to the Committee's purpose. The organizational representatives are non-voting liaisons. The Committee provides advice, recommendations, and technical information about aspects of heritable disorders and newborn and childhood screening to the Secretary of HHS.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 59 (Monday, March 28, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 59 (Monday, March 28, 2022)]
[Notices]
[Pages 17307-17308]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-06368]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Solicitation of Nominations for Organizational Representatives to
the Advisory Committee on Heritable Disorders in Newborns and Children
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Request for nominations.
-----------------------------------------------------------------------
SUMMARY: HRSA is seeking nominations from organizations to send
representatives to be a liaison to the Advisory Committee on Heritable
Disorders in Newborns and Children (ACHDNC or Committee). Selections
will be based on a review of the organization's subject area of
expertise, mission, relevancy, and benefit provided relative to the
Committee's purpose. The organizational representatives are non-voting
liaisons. The Committee provides advice, recommendations, and technical
information about aspects of heritable disorders and newborn and
childhood screening to the Secretary of HHS.
DATES: Written nominations for organizational representatives to the
ACHDNC must be received on or before May 2, 2022.
ADDRESSES: Nomination packages must be submitted electronically as
email attachments to Soohyun Kim, MPH, CPH, Acting Designated Federal
Officer (DFO) at <a href="/cdn-cgi/l/email-protection#b1f0f2f9f5fff2f1d9c3c2d09fd6dec7"><span class="__cf_email__" data-cfemail="1f5e5c575b515c5f776d6c7e31787069">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Acting DFO Soohyun Kim, MPH, CPH;
Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Room 18-N-
38A, Rockville, MD 20857; 301-594-4202; or <a href="/cdn-cgi/l/email-protection#30717378747e7370584243511e575f46"><span class="__cf_email__" data-cfemail="d697959e92989596bea4a5b7f8b1b9a0">[email protected]</span></a>. A copy of
the Committee charter and list of current membership is available on
the Committee's website: <a href="https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html">https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html</a>.
SUPPLEMENTARY INFORMATION: ACHDNC was established in 2003 to provide
advice and recommendations to the Secretary on the development of
newborn screening activities, technologies, policies, guidelines, and
programs for effectively reducing morbidity and mortality in newborns
and children having, or at risk for, heritable disorders. ACHDNC
reviews and reports regularly on newborn and childhood screening
practices for heritable disorders, recommends improvements in the
national newborn and childhood heritable screening programs, recommends
conditions for inclusion in the Recommended Uniform Screening Panel
(RUSP), and fulfills requirements stated in the authorizing
legislation. ACHDNC's recommendations regarding inclusion of additional
conditions/inherited disorders for screening that, when adopted by the
Secretary, are included in the RUSP, and constitute part of the
evidence-informed comprehensive preventive health services guidelines
supported by HRSA pursuant to section 2713 of the Public Health Service
Act (42 U.S.C. 300gg-13). Under this provision, non-grandfathered group
health plans and group and individual health insurance issuers are
required to provide coverage without cost-sharing (a co-payment, co-
insurance, or deductible) for preventive services for plan years (i.e.,
in the individual market, policy years) beginning on or
[[Page 17308]]
after the date that is 1 year from the Secretary's adoption of the
condition.
ACHDNC also provides advice and recommendations to the Secretary
concerning grants, projects and technical information to develop
policies and priorities for grants, including those that will enhance
the ability of the state and local health agencies to provide for
newborn and child screening, counseling, and health care services for
newborns and children having or at risk for heritable disorders.
ACHDNC meets four times each calendar year, or at the discretion of
the DFO in consultation with the Chair.
Nominations: The Committee may invite organizations to designate
individuals to serve as non-voting liaisons. Organizations should
demonstrate wide-ranging newborn screening and heritable disorders
interests. In addition, the organization's work should inform the
activities of the Committee. Eligible organizations must represent
national public health constituencies, medical professional societies,
or organizations with large, broad constituencies and broad interest or
involvement in newborn screening. Organizations that represent narrow
interests (e.g., interest in a single disease treatment) or smaller
constituencies are not eligible. Organizational representatives attend
Committee meetings to provide relevant expertise and perspectives to
Committee members during their deliberations and discussions, but they
do not vote and are not official members of the Committee.
Applications must contain a cover letter and statement. The cover
letter should include the organization name and mission statement;
contact information for the designated representative, including point
of contact name, address, email, telephone number; and website of the
organization. The statement should include the perspective and
expertise provided by the organization and its relevance to the
Committee; description of how the Committee's work affects and impacts
the organization and its constituency; a list of organizational
projects, programs, and products that are of relevance to the
Committee's work; an affirmation of the organization's commitment to
identify a representative with expertise who can attend Committee
meetings in person (when applicable) and provide input to the Committee
at the discretion of the Chair; an affirmation of the organization's
commitment to financially support (e.g., cover travel expenses) a
representative to attend any in-person Committee meetings held in
Rockville, Maryland; an affirmation of the organization's commitment to
ensure active contribution to and dissemination of Committee activities
and recommendations to its constituencies; affirmation the designated
representative is able to serve as the liaison; and an affirmation that
the organization has no conflict of interest that would preclude
informing the Committee in a fair and balanced manner. If there are
potential conflicts of interest, please detail the information
concerning any potential conflicts of interest relative to both the
organization and the proposed organizational representative (e.g.,
current or anticipated employment, consultancies, research grants, or
contracts), as well as how the organization proposes to address the
potential conflict.
Organizations are eligible to send a representative as long as the
organization's subject area of expertise and mission is relevant to the
Committee's purpose, objective, scope of activities and duties, and as
long as the organization actively participates in Committee activities.
Every 3 years, the Chair and DFO will re-assess the organization's
mission, relevancy, and benefit as it relates to the Committee's
purpose, objective, scope of activities and duties. Every 3 years,
current organizations will be asked to reaffirm their commitment to
support an organizational representative.
The selection of eligible organizations is based on a review of the
organization's subject area of expertise, mission, relevancy, and
benefit as it relates to the Committee's purpose.
Authority: Section 1111(g) of the Public Health Service Act, 42
U.S.C. 300b-10(g), Section 222 of the Public Health Service Act, 42
U.S.C. 217a, and the Federal Advisory Committee Act, 5 U.S.C. App.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-06368 Filed 3-25-22; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 28, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.